BIO-KEY INTERNATIONAL INC (BKYI) Fundamental Analysis & Valuation

NASDAQ:BKYI • US09060C5076

Current stock price

0.648 USD
-0.01 (-2.11%)
At close:
0.625 USD
-0.02 (-3.55%)
Pre-Market:

This BKYI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BKYI Profitability Analysis

1.1 Basic Checks

  • BKYI had negative earnings in the past year.
  • BKYI had a negative operating cash flow in the past year.
  • BKYI had negative earnings in each of the past 5 years.
  • In the past 5 years BKYI always reported negative operating cash flow.
BKYI Yearly Net Income VS EBIT VS OCF VS FCFBKYI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

  • BKYI's Return On Assets of -42.06% is on the low side compared to the rest of the industry. BKYI is outperformed by 81.95% of its industry peers.
  • BKYI has a Return On Equity of -70.36%. This is in the lower half of the industry: BKYI underperforms 73.65% of its industry peers.
Industry RankSector Rank
ROA -42.06%
ROE -70.36%
ROIC N/A
ROA(3y)-114.53%
ROA(5y)-83.12%
ROE(3y)-379.98%
ROE(5y)-244.11%
ROIC(3y)N/A
ROIC(5y)N/A
BKYI Yearly ROA, ROE, ROICBKYI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

  • BKYI's Gross Margin of 78.40% is fine compared to the rest of the industry. BKYI outperforms 76.17% of its industry peers.
  • In the last couple of years the Gross Margin of BKYI has grown nicely.
  • The Profit Margin and Operating Margin are not available for BKYI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.53%
GM growth 5YN/A
BKYI Yearly Profit, Operating, Gross MarginsBKYI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. BKYI Health Analysis

2.1 Basic Checks

  • BKYI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BKYI has more shares outstanding
  • BKYI has more shares outstanding than it did 5 years ago.
  • BKYI has a worse debt/assets ratio than last year.
BKYI Yearly Shares OutstandingBKYI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BKYI Yearly Total Debt VS Total AssetsBKYI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • BKYI has an Altman-Z score of -17.81. This is a bad value and indicates that BKYI is not financially healthy and even has some risk of bankruptcy.
  • BKYI has a Altman-Z score of -17.81. This is amonst the worse of the industry: BKYI underperforms 92.42% of its industry peers.
  • A Debt/Equity ratio of 0.22 indicates that BKYI is not too dependend on debt financing.
  • BKYI has a Debt to Equity ratio of 0.22. This is comparable to the rest of the industry: BKYI outperforms 44.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z -17.81
ROIC/WACCN/A
WACC11.83%
BKYI Yearly LT Debt VS Equity VS FCFBKYI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • BKYI has a Current Ratio of 1.26. This is a normal value and indicates that BKYI is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.26, BKYI is doing worse than 62.82% of the companies in the same industry.
  • A Quick Ratio of 1.13 indicates that BKYI should not have too much problems paying its short term obligations.
  • The Quick ratio of BKYI (1.13) is worse than 68.59% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.13
BKYI Yearly Current Assets VS Current LiabilitesBKYI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BKYI Growth Analysis

3.1 Past

  • BKYI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 90.55%, which is quite impressive.
  • BKYI shows a decrease in Revenue. In the last year, the revenue decreased by -1.19%.
  • The Revenue has been growing by 25.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)90.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
Revenue 1Y (TTM)-1.19%
Revenue growth 3Y10.69%
Revenue growth 5Y25.01%
Sales Q2Q%-27.78%

3.2 Future

  • BKYI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.20% yearly.
  • The Revenue is expected to grow by 7.75% on average over the next years.
EPS Next Y73.12%
EPS Next 2Y35.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.83%
Revenue Next 2Y7.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BKYI Yearly Revenue VS EstimatesBKYI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
BKYI Yearly EPS VS EstimatesBKYI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -20 -40 -60 -80 -100

More info and screens

Find the best growth stocksShow best growing peers

1

4. BKYI Valuation Analysis

4.1 Price/Earnings Ratio

  • BKYI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year BKYI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKYI Price Earnings VS Forward Price EarningsBKYI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BKYI Per share dataBKYI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

  • BKYI's earnings are expected to grow with 35.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.2%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BKYI Dividend Analysis

5.1 Amount

  • No dividends for BKYI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BKYI Fundamentals: All Metrics, Ratios and Statistics

BIO-KEY INTERNATIONAL INC

NASDAQ:BKYI (3/13/2026, 8:11:50 PM)

Premarket: 0.625 -0.02 (-3.55%)

0.648

-0.01 (-2.11%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-14
Earnings (Next)03-25
Inst Owners1.57%
Inst Owner Change23.38%
Ins Owners3.82%
Ins Owner Change0.33%
Market Cap7.02M
Revenue(TTM)6.32M
Net Income(TTM)-4.25M
Analysts82.86
Price Target2.04 (214.81%)
Short Float %2.34%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.63%
Min EPS beat(2)-30.72%
Max EPS beat(2)-22.55%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.88%
Min Revenue beat(2)-15.63%
Max Revenue beat(2)-2.13%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.11
P/FCF N/A
P/OCF N/A
P/B 1.16
P/tB 1.36
EV/EBITDA N/A
EPS(TTM)-0.96
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0.58
BVpS0.56
TBVpS0.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -42.06%
ROE -70.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.4%
FCFM N/A
ROA(3y)-114.53%
ROA(5y)-83.12%
ROE(3y)-379.98%
ROE(5y)-244.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.53%
GM growth 5YN/A
F-Score4
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.7%
Cap/Sales 0.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.13
Altman-Z -17.81
F-Score4
WACC11.83%
ROIC/WACCN/A
Cap/Depr(3y)8.01%
Cap/Depr(5y)11.47%
Cap/Sales(3y)0.45%
Cap/Sales(5y)0.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
EPS Next Y73.12%
EPS Next 2Y35.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.19%
Revenue growth 3Y10.69%
Revenue growth 5Y25.01%
Sales Q2Q%-27.78%
Revenue Next Year-5.83%
Revenue Next 2Y7.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y58.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y20.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.44%
OCF growth 3YN/A
OCF growth 5YN/A

BIO-KEY INTERNATIONAL INC / BKYI Fundamental Analysis FAQ

What is the fundamental rating for BKYI stock?

ChartMill assigns a fundamental rating of 2 / 10 to BKYI.


What is the valuation status for BKYI stock?

ChartMill assigns a valuation rating of 1 / 10 to BIO-KEY INTERNATIONAL INC (BKYI). This can be considered as Overvalued.


How profitable is BIO-KEY INTERNATIONAL INC (BKYI) stock?

BIO-KEY INTERNATIONAL INC (BKYI) has a profitability rating of 1 / 10.


What is the earnings growth outlook for BIO-KEY INTERNATIONAL INC?

The Earnings per Share (EPS) of BIO-KEY INTERNATIONAL INC (BKYI) is expected to grow by 73.12% in the next year.


How sustainable is the dividend of BIO-KEY INTERNATIONAL INC (BKYI) stock?

The dividend rating of BIO-KEY INTERNATIONAL INC (BKYI) is 0 / 10 and the dividend payout ratio is 0%.